Chromosomal localization of the type-I 15-PGDH gene to 4q34–q35

[1]  A. Ristimäki,et al.  Cyclooxygenase Gene Expression in Inflammation and Angiogenesis a , 1993, Annals of the New York Academy of Sciences.

[2]  G Lanzi,et al.  A complex chromosome rearrangement with 10 breakpoints: tentative assignment of the locus for Williams syndrome to 4q33----q35.1. , 1992, Journal of medical genetics.

[3]  H. Tai,et al.  Cloning and sequence analysis of the cDNA for human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase. , 1990, The Journal of biological chemistry.

[4]  H. Jörnvall,et al.  Purification and structural characterization of placental NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase. The primary structure reveals the enzyme to belong to the short-chain alcohol dehydrogenase family. , 1990, Biochemistry.

[5]  G. Lenoir,et al.  Elevated plasma 1,25-dihydroxyvitamin D concentrations in infants with hypercalcemia and an elfin facies. , 1985, The New England journal of medicine.

[6]  E. Ogata,et al.  Inhibition by prostaglandin E2 of renal effects of calcitonin in rats. , 1985, Endocrinology.

[7]  B. Roos,et al.  Calcitonin secretion by monolayer cultures of human C-cells derived from medullary thyroid carcinoma. , 1975, Endocrinology.

[8]  E. Anggard,et al.  The Distribution of 15-Hydroxy Prosta-glandin Dehydrogenase and Prostaglandin-Δ13-Reductase in Tissues of the Swine , 1971 .

[9]  Kenneth L. Jones,et al.  Impaired calcitonin secretion Williams syndrome in patients with , 1985 .

[10]  E. Anggard.  The biological activities of three metabolites of prostaglandin E 1. , 1966, Acta physiologica Scandinavica.